Stock listing

0UNL Stock Price, News, Filings & Events — Nektar Therapeutics

Selected listing: 0UNL · LSE · USD · GB

The 0UNL:LSE listing represents Nektar Therapeutics, a biopharmaceutical company focused on discovering and developing innovative therapies for patients with serious diseases. The company is engaged in advancing its pipeline of drug candidates, which includes treatments for cancer and autoimmune diseases. Recent news highlights Nektar's ongoing clinical trials and collaborations aimed at enhancing its therapeutic offerings. Investors can find the latest filings and updates on corporate events that may impact the company's market position.

0UNL:LSEUSDGBUpdated July 24, 2026
Nektar Therapeutics logo
Ticker
0UNL:LSE
Asset type
Stock
Market cap
$2.39B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LSE
Currency
USD

Nektar Therapeutics 0UNL:LSE stock context

The 0UNL:LSE listing represents Nektar Therapeutics, a biopharmaceutical company focused on discovering and developing innovative therapies for patients with serious diseases. The company is engaged in advancing its pipeline of drug candidates, which includes treatments for cancer and autoimmune diseases. Recent news highlights Nektar's ongoing clinical trials and collaborations aimed at enhancing its therapeutic offerings. Investors can find the latest filings and updates on corporate events that may impact the company's market position.

Research Nektar Therapeutics

Alternate listings